VistaGen Therapeutics, Inc. Gains 27.1%

Mon, Feb 13, 2023 at 07:22 PM
VistaGen Therapeutics, Inc. Gains 27.1%

VistaGen Therapeutics, Inc. (VTGN:NASDAQ) rocketted at $0.23, representing a gain of 27.1%. The stock got featured on our News Catalysts scanner on Tue, Feb 07, 2023 at 04:53 PM in the 'INVESTOR UPDATE' category. From Mon, Jan 30, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days

The stock spiked on Mon, Feb 06, 2023 at $0.34 with a volume of 13M+.

About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)

VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.